Delivery systems to increase the selectivity of antibiotics in phagocytic cells

被引:163
作者
Briones, Elsa [1 ]
Colino, Clara Isabel [1 ]
Lanao, Jose M. [1 ]
机构
[1] Univ Salamanca, Fac Pharm, Dept Pharm & Pharmaceut Technol, Salamanca 37007, Spain
关键词
delivery systems; antibiotics; phagocytic cells; intracellular infections; selectivity;
D O I
10.1016/j.jconrel.2007.10.027
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Many infectious diseases are caused by facultative organisms that are able to survive in phagocytic cells. The intracellular location of these microorganisms protects them from the host defence systems and from some antibiotics with poor penetration into phagocytic cells. One strategy used to improve the penetration of antibiotics into phagocytic cells is the use of carrier systems that deliver these drugs directly to the target cell. Delivery systems such as liposomes, micro/nanoparticles, lipid systems, conjugates, and biological carriers such as erythrocyte ghosts may contribute to increasing the therapeutic efficacy of antibiotics and antifungal agents in the treatment of infections caused by intracellular microorganisms. The main objective of this review is to analyze recent advances and current perspectives in the use of antibiotic delivery systems in the treatment of intracellular infections such as mycobacterial infections, brucellosis, salmonellosis, lysteriosis, fungal infections, visceral leishmaniasis, and HIV (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:210 / 227
页数:18
相关论文
共 210 条
[21]   Survival of human carrier erythrocytes in vivo [J].
Bax, BE ;
Bain, MD ;
Talbot, PJ ;
Parker-Williams, EJ ;
Chalmers, RA .
CLINICAL SCIENCE, 1999, 96 (02) :171-178
[22]   Azidothymidine homodinucleotide-loaded erythrocytes as bioreactors for slow delivery of the antiretroviral drug azidothymidine [J].
Benatti, U ;
Giovine, M ;
Damonte, G ;
Gasparini, A ;
Scarfi, S ;
DeFlora, A ;
Fraternale, A ;
Rossi, L ;
Magnani, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (01) :20-25
[23]   Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro [J].
Bender, AR ;
vonBriesen, H ;
Kreuter, J ;
Duncan, IB ;
RubsamenWaigmann, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1467-1471
[24]   USE OF LIPOSOME PREPARATION TO TREAT MYCOBACTERIAL INFECTIONS [J].
BERMUDEZ, LE .
IMMUNOBIOLOGY, 1994, 191 (4-5) :578-583
[25]   Liposomal amphotericin B for the treatment of visceral leishmaniasis [J].
Bern, Caryn ;
Adler-Moore, Jill ;
Berenguer, Juan ;
Boelaert, Marleen ;
den Boer, Margriet ;
Davidson, Robert N. ;
Figueras, Concepcion ;
Gradoni, Luigi ;
Kafetzis, Dimitris A. ;
Ritmeijer, Koert ;
Rosenthal, Eric ;
Royce, Catherine ;
Russo, Rosario ;
Sundar, Shyam ;
Alvar, Jorge .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :917-924
[26]   Comparison of the effects of dimyristoyl and soya phosphatidylcholine liposomes on human fibroblasts [J].
Berrocal, MC ;
Buján, J ;
García-Honduvilla, N ;
Abeger, A .
DRUG DELIVERY, 2000, 7 (01) :37-44
[27]   PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate [J].
Bhadra, D ;
Bhadra, S ;
Jain, NK .
PHARMACEUTICAL RESEARCH, 2006, 23 (03) :623-633
[28]   CELLULAR UPTAKE, LOCALIZATION AND ACTIVITY OF FLUOROQUINOLONES IN UNINFECTED AND INFECTED MACROPHAGES [J].
CARLIER, MB ;
SCORNEAUX, B ;
ZENEBERGH, A ;
DESNOTTES, JF ;
TULKENS, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 :27-39
[29]   Intracellular pharmacodynamics of antibiotics [J].
Carryn, S ;
Chanteux, H ;
Seral, C ;
Mingeot-Leclercq, MP ;
Van Bambeke, F ;
Tulkens, PM .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (03) :615-+
[30]   Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani [J].
Carter, KC ;
Mullen, AB ;
Sundar, S ;
Kenney, RT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3555-3559